摘要 |
This invention relates to compounds of formula I wherein R<SUP>1 </SUP>and R<SUP>2 </SUP>are defined herein, or a pharmaceutically acceptable salt thereof. It has been found that the compounds of formula I are adenosine receptor ligands with good affinity to the A<SUB>2A</SUB>-receptor and a high selectivity to the A<SUB>1</SUB>- and A<SUB>3 </SUB>receptors. These compounds are useful, inter alia, in treatment of Alzheimer's disease, depression, Parkinson's disease and ADHD.
|